A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

BACKGROUND: There is evidence suggesting that sirolimus, in combination with tacrolimus, is active in the prevention of graft-versus-host disease. Sirolimus-based immune suppression may suppress alloreactive T cells, while sparing the survival and function of regulatory T cells. DESIGN AND METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pidala, Joseph, Kim, Jongphil, Jim, Heather, Kharfan-Dabaja, Mohamed A., Nishihori, Taiga, Fernandez, Hugo F., Tomblyn, Marcie, Perez, Lia, Perkins, Janelle, Xu, Mian, Janssen, William E., Veerapathran, Anandaraman, Betts, Brian C., Locke, Frederick L., Ayala, Ernesto, Field, Teresa, Ochoa, Leonel, Alsina, Melissa, Anasetti, Claudio
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2012
Témata:
Original Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590095/
https://ncbi.nlm.nih.gov/pubmed/22689677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.067140
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky